COURSE DESCRIPTION AND OBJECTIVES
The Anesthesiology Update 2018 has as its basic theme a critical evaluation of current practices of anesthesia. Consequently, the program contains state of the art elements in all the anesthesia subspecialties and discusses important new problems and their solutions which can be incorporated by the participants. The content of the program is designed for and attracts a mixed audience consisting of anesthesiologists, CRNA’s and other providers involved in perioperative care.
At the conclusion of this activity participants should be able to: apply new American Heart Association preoperative guidelines to their practice; apply new cardiovascular monitoring indices such as Stroke Volume Variation in managing fluid administration; use ultrasound technology in their practice of Regional Anesthesia; apply the American Society of Regional Anesthesia Guidelines for the performance of regional anesthesia in anti-coagulated patients; use advanced airway techniques and apply the latest American Society of Anesthesiologists guidelines in management of the difficult airway; and apply evidence-based principles in the prevention of postoperative nausea and vomiting. In addition, they will be able to apply ethical principles in managing perioperative dilemmas and potential conflicts of interest.
The content of this educational program was determined by rigorous assessment of educational need and includes review of prior course evaluations, faculty assessment, as well as new medical knowledge that has been incorporated into the program.
Following the traditional format of our previous Anesthesiology Update programs, the speakers will focus on i.e., point of care ultrasound, enhanced recovery, multimodal perioperative pain management, and perioperative assessment (including genomics); there will also be emphasize on clinical anesthesia management, and regional anesthesia airway management.
Our speakers are well recognized and distinguished experts in their subspecialty fields. At the conclusion of each speaker’s presentation, ample time has been reserved for questions & answers.
The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANA: Upon approval by the American Association of Nurse Anesthetists, CRNAs will be eligible for CE credits.
CULTURAL AND LINGUISTIC COMPETENCY
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge and skills that enable health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient's primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB 1195 can be found on the UC San Diego CME website.
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms: 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.